PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. niloufar@hku.hk.\', \'Faculté de Médecine Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire Cochin, Service d\'Immunologie Biologique, Paris, France. niloufar@hku.hk.\', \'Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. niloufar@hku.hk.\', \'Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.\', \'HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. sophiev@hku.hk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41590-020-0773-7
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 32807944
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
?:title
  • ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all